uuid,short_id,hypothesis,categories,paper,questions,data_folder
33b801bb-9b47-4a0a-9314-05325c82fde7,bix-1,"Truncating ASXL1 mutations will lead to specific gene expression changes in blood that reflect alterations in hematological processes, such as T cell and neutrophil activation.","['RNA-seq', 'Differential Expression Analysis', 'Transcriptomics', 'Network Biology']",https://doi.org/10.1172/jci.insight.167744,"[{""question"": ""What is the adjusted p-val threshold for T-cell activation related processes found in the GO enrichment?"", ""options"": [""p-adj < 0.01 for any immune process"", ""log2FoldChange > 1.5 for T cell genes"", ""raw p-value < 0.05 for T cell terms"", ""p-adj < 0.05 for T cell activation terms""]}, {""question"": ""How many GO terms related to immune processes must show p-adj < 0.05 to establish significant enrichment of immune pathways in the dataset?"", ""options"": [""At least 10 terms"", ""At least 50% of all immune-related terms"", ""At least 1 term"", ""All immune-related terms""]}, {""question"": ""What variable must be included in the DESeq2 design formula to properly analyze the effect of ASXL1 mutations in a mixed-gender cohort?"", ""options"": [""batch number"", ""sex"", ""age"", ""sample name""]}, {""question"": ""What clinical feature or criterion should be used as an exclusion factor for patients recruited in the study"", ""options"": [""Age of the patient"", ""Presence of confounding medical conditions"", ""Genetic background"", ""Low sequencing depth""]}, {""question"": ""What is the adjusted p-value for neutrophil activation in the gene ontology analysis?"", ""options"": [""4.56E-4"", ""1.90E-5"", ""2.15E-6"", ""3.23E-8""]}]",CapsuleFolder-33b801bb-9b47-4a0a-9314-05325c82fde7.zip
30b33e47-92d8-4372-a9f6-da32896493d0,bix-2,"Bloom Syndrome (BSyn) probands and BLM mutation carriers will have a higher mean proportion of low-frequency, somatic CHIP gene variants (VAF < 0.3) compared to control cohorts, given that mutations in the BLM gene are known to cause increased genomic instability.","['Genomics', 'Genomic Variant Analysis']",doi.org/10.3324/haematol.2024.285239,"[{""question"": ""What is the proportion of likely somatic variants (VAF < 0.3) in BLM carriers relative to the total number of CHIP variants identified in this group?"", ""options"": [""0.45"", ""0.15"", ""0.25"", ""0.05""]}, {""question"": ""What is the percentage of CHIP variants with VAF between 0.3 and 0.7 in the Control Children cohort?"", ""options"": [""65%"", ""55%"", ""75%"", ""45%""]}, {""question"": ""What proportion of CHIP variants fall into the exonic regions of the genome?"", ""options"": [""38.2%"", ""45.5%"", ""52.3%"", ""58.7%""]}, {""question"": ""What is the average number of CHIP variants per sample that pass all quality filters (DP>10, GQ>20, PASS) in the exonic regions?"", ""options"": [""35"", ""89"", ""71"", ""53""]}]",CapsuleFolder-30b33e47-92d8-4372-a9f6-da32896493d0.zip
94bcdbc9-c729-4661-9bc1-0057bbea39c4,bix-3,Antidepressant Paroxetine has negligible effects on gene expression in control (non-depressed) mice,"['Differential Expression Analysis', 'Transcriptomics', 'RNA-seq']",https://zenodo.org/records/4287588,"[{""question"": ""What's the number of genes that are differentially regulated, when comparing final vs baseline blood?"", ""options"": [""<1000"", ""10000"", ""5000"", "">15000""]}, {""question"": ""What is the 95% confidence interval for the proportion of differentially expressed genes in the final vs baseline blood comparison?"", ""options"": [""(0.0281, 0.0323)"", ""(0.4563, 0.4685)"", ""(0.0312, 0.0356)"", ""(0.4530, 0.4653)""]}, {""question"": ""How many genes show differential expression uniquely in the dentate gyrus vs baseline blood comparison after excluding genes shared with other comparisons?"", ""options"": [""766"", ""11663"", ""429"", ""846""]}, {""question"": ""How many genes show consistent differential expression across all three tissue comparisons (final vs baseline blood, dentate gyrus vs baseline blood, and dentate gyrus vs final blood)?"", ""options"": [""10316"", ""429"", ""773"", ""11746""]}, {""question"": ""In a differential expression analysis comparing treatment effects in blood samples, what proportion of genes would need to show significant changes (padj < 0.05, |log2FC| > 1) to reject the hypothesis of negligible treatment effects?"", ""options"": [""Any number of significantly changed genes"", ""More than 10% of total genes"", ""More than 1% of total genes"", ""More than 5% of total genes""]}]",CapsuleFolder-94bcdbc9-c729-4661-9bc1-0057bbea39c4.zip
ec9eb551-feee-48f6-8494-fd85e1521881,bix-4,Fungi have a more clock-like pattern of evolution compared to animals.,"['Whole Genome Sequencing (WGS)', 'Genomics', 'Phylogenetics and Evolutionary Analysis']",Not Available,"[{""question"": ""What percentage of fungal genes in the dataset exhibit DVMC values below 0.3, indicating strong clock-like evolution?"", ""options"": [""45%"", ""57%"", ""28%"", ""79%""]}, {""question"": ""What is the mean DVMC value for genes within the animal dataset?"", ""options"": [""0.57"", ""0.82"", ""0.65"", ""0.31""]}, {""question"": ""What is the Mann Whitney U value between fungi and animal DVMC values?"", ""options"": [""19808"", ""9340"", ""18356"", ""16032""]}, {""question"": ""What is the standard deviation of DVMC values among genes in the animal dataset?"", ""options"": [""0.56"", ""0.30"", ""0.28"", ""0.15""]}, {""question"": ""What is the median DVMC value for fungal genes?"", ""options"": [""0.35"", ""0.27"", ""0.65"", ""0.52""]}, {""question"": ""What is the highest DVMC value observed among animal genes?"", ""options"": [""1.58"", ""1.22"", ""0.95"", ""1.05""]}, {""question"": ""What is the DVMC value for the orthologous gene 324863at2759 in fungi?"", ""options"": [""0.99"", ""0.67"", ""0.45"", ""0.32""]}]",CapsuleFolder-ec9eb551-feee-48f6-8494-fd85e1521881.zip
2a8a40d4-05b0-4eec-8bd2-825f61fc9f5d,bix-5,"Truncating ASXL1 mutations that cause Bohring-Opitz syndrome (BOS) will cause specific transcriptional changes that are tissue-specific, such as processes related to cellular structure in patient-derived fibroblast cell culture.","['RNA-seq', 'Differential Expression Analysis', 'Transcriptomics', 'Network Biology']",https://doi.org/10.1172/jci.insight.167744,"[{""question"": ""Which is statistically the most enriched GO process in BOS-patient fibroblasts?"", ""options"": [""Dendrite self-avoidance"", ""Potassium ion transmembrane transport"", ""Muscle contraction"", ""Axon guidance""]}, {""question"": ""What is the lowest adjusted p-value threshold of membrane potential regulation processes resulting from the enrichment?"", ""options"": [""0.02"", ""0.04"", ""0.03"", ""0.01""]}, {""question"": ""How many independent ion transport-related processes are significantly enriched in the GO analysis results?"", ""options"": [""4"", ""2"", ""3"", ""1""]}, {""question"": ""What impact would reducing the GO term similarity cutoff from 0.7 to 0.5 in the simplification step have on the number of significant membrane-related processes?"", ""options"": [""Decrease the number of significant terms"", ""Increase the number of significant terms"", ""Remove all membrane-related terms"", ""No change in the number of terms""]}, {""question"": ""Which is the most enriched process in the ASXL1-mutated fibroblasts?"", ""options"": [""Potassium ion transmembrane transport"", ""Dendrite self-avoidance"", ""Axon guidance"", ""Muscle contraction""]}, {""question"": ""For a given set of differentially expressed genes in fibroblasts, what is the adjusted p-value threshold used to determine significant GO term enrichment?"", ""options"": [""0.05"", ""0.001"", ""0.02"", ""0.01""]}, {""question"": ""What similarity cutoff value is used to reduce redundancy in the GO term analysis?"", ""options"": [""0.7"", ""0.5"", ""0.6"", ""0.8""]}]",CapsuleFolder-2a8a40d4-05b0-4eec-8bd2-825f61fc9f5d.zip
f4dcda89-678d-403d-b155-1483d0071765,bix-6,"Immune-relevant pathways will be enriched within the set of genes that, when perturbed, enable cancer cells to evade T cell-mediated cytotoxicity.",['Functional Genomics'],https://www.nature.com/articles/s41467-022-29205-8#Abs1,"[{""question"": ""Based on the pathway enrichment analysis of T cell evasion genes, at what timepoint does immune pathway regulation show the strongest evidence of selective pressure?"", ""options"": [""During chronic round 3 (day 9)"", ""During chronic round 1 (day 3)"", ""During chronic round 2 (day 6)"", ""During acute (18-hour) exposure""]}, {""question"": ""What is the adjusted p-value threshold required to identify significant pathway enrichment in the acute T cell exposure analysis?"", ""options"": [""0.05"", ""0.01"", ""No pathways meet any significance threshold"", ""0.001""]}, {""question"": ""How many pathways maintain significant enrichment (adjusted p-value < 0.05) across all three rounds of chronic T cell exposure?"", ""options"": [""0 pathways"", ""1 pathway"", ""4 pathways"", ""2 pathways""]}, {""question"": ""What is the Spearman correlation coefficient between replicates for genes identified in chronic round 1 of T cell exposure?"", ""options"": [""0.013"", ""0.021"", ""0.020"", ""0.014""]}, {""question"": ""What proportion of screening conditions showed significant enrichment of immune-relevant pathways in genes associated with T cell evasion?"", ""options"": [""2/4 conditions"", ""1/4 conditions"", ""0/4 conditions"", ""3/4 conditions""]}, {""question"": ""What correlation value is observed between replicates in the acute T cell screen?"", ""options"": [""0.021"", ""0.047"", ""0.014"", ""0.198""]}, {""question"": ""In chronic screen round 2, what is the odds ratio for the most significantly enriched pathway?"", ""options"": [""6.17"", ""7.43"", ""1.29"", ""9.41""]}]",CapsuleFolder-f4dcda89-678d-403d-b155-1483d0071765.zip
a02b761a-02b6-46b5-9d5e-2964d5a74960,bix-7,"Bloom Syndrome (BSyn) probands and BLM mutation carriers will have similar levels of germline mutations to controls, but will acquire more DNA mutations, resulting in a higher number of somatic variants, given that Bloom Syndrome is characterized by increased genomic instability. ","['Genomics', 'Genomic Variant Analysis']",https://doi.org/10.3324/haematol.2024.285239,"[{""question"": ""What is the relationship between BLM mutation status and CHIP variant frequency in the analyzed exome sequencing data?"", ""options"": [""Control parents show significantly lower CHIP variant frequencies than other groups"", ""BSyn probands show significantly higher CHIP variant frequencies than controls"", ""BLM carriers show intermediate CHIP variant frequencies between BSyn probands and controls"", ""CHIP variant frequencies show no statistically significant differences between groups""]}, {""question"": ""What is the average number of CHIP variants per sample after filtering out intronic, intergenic, and UTR variants?"", ""options"": [""100-150 variants"", ""25-35 variants"", ""200-250 variants"", ""40-60 variants""]}, {""question"": ""How many CHIP variants remain after removing reference calls from the dataset?"", ""options"": [""40k-50k"", ""50-60k"", ""15k-25k"", ""10k-20k""]}, {""question"": ""How many distinct sample groups are represented in the final CHIP variant analysis after proper classification of control samples?"", ""options"": [""3 groups"", ""2 groups"", ""5 groups"", ""4 groups""]}]",CapsuleFolder-a02b761a-02b6-46b5-9d5e-2964d5a74960.zip
48a6b469-9c9d-4bef-b5b4-f29b7d6fa046,bix-8,mRNA m6A methylation plays a significant role in the development of human bladder cancer,"['Epigenomics', 'Differential Expression Analysis', 'RNA-seq']",10.17632/dj4sb8h3c3.1,"[{""question"": ""What proportion of hypermethylated genes (m6A Hyper) in the dataset show increased expression (Up) in bladder cancer?"", ""options"": [""0.082 (8.2%)"", ""0.327 (32.7%)"", ""0.156 (15.6%)"", ""0.234 (23.4%)""]}, {""question"": ""What is the chi-square statistic for the independence test between m6A methylation status and differential expression status in the dataset?"", ""options"": [""433.2"", ""901.45"", ""562.3"", ""119.8""]}, {""question"": ""What is the ratio of hypermethylated to hypomethylated genes among all differentially methylated genes in the dataset?"", ""options"": [""1.85"", ""2.15"", ""1.33"", ""0.75""]}, {""question"": ""For genes with significant differential methylation, what is the odds ratio of finding upregulated versus downregulated genes in hypermethylated compared to hypomethylated genes?"", ""options"": [""8.8"", ""12.5"", ""4.2"", ""74.3""]}, {""question"": ""What is the p-value of the statistical test examining the independence between m6A methylation status and differential expression in bladder cancer?"", ""options"": [""p < 2.2e-16"", ""p > 0.05"", ""p = 0.001"", ""p = 0.0338""]}, {""question"": ""How many genes show significant hypermethylation in bladder cancer samples?"", ""options"": [""680"", ""415"", ""511"", ""11563""]}]",CapsuleFolder-48a6b469-9c9d-4bef-b5b4-f29b7d6fa046.zip
873bada5-b1f3-423a-87dc-9ddd486c4843,bix-9,Paroxetine induces tissue-specific gene expression changes in depressed mice,"['Differential Expression Analysis', 'Transcriptomics', 'RNA-seq']",https://zenodo.org/records/4287588,"[{""question"": ""By performing a two-way ANOVA analysis on the gene expression data, what is the statistical strength (F-statistic and p-value) of the interaction between tissue type and treatment response?"", ""options"": [""F = 10.09 (p < 0.0001)"", ""F = 3.24 (p > 0.05)"", ""F = 33.90 (p < 0.0001)"", ""F = 1.07 (p > 0.05)""]}, {""question"": ""How many differentially expressed genes are shared between brain tissue and blood samples in bad responders versus controls?"", ""options"": [""156 genes"", ""2 genes"", ""312 genes"", ""47 genes""]}, {""question"": ""In the dentate gyrus, what is the pattern of overlap in differentially expressed genes between good responders, bad responders, and controls?"", ""options"": [""Complete overlap between all groups"", ""Complete overlap between good responders and controls only"", ""No overlap between any groups"", ""Partial overlap between good and bad responders only""]}, {""question"": ""What is the statistical significance level (p-value) of the Category effect in the one-way ANOVA testing for tissue-response interactions? (\""Category\"" here means the concatenation of \""Tissue\"" and \""Response\"")"", ""options"": [""p = 1.07e-16"", ""p = 3.39e-12"", ""p = 9.92e-35"", ""p = 4.26e-6""]}, {""question"": ""In which tissue type do bad responders show the highest number of significant (p < 0.05) differentially expressed genes compared to controls?"", ""options"": [""Dentate gyrus (brain)"", ""Equal numbers across all tissues"", ""Final blood"", ""Baseline blood""]}]",CapsuleFolder-873bada5-b1f3-423a-87dc-9ddd486c4843.zip
fbe0e950-76f2-4eb7-a216-a2d377970922,bix-10,Tubercolosis BCG re-vaccination reduces COVID-19 disease severity among healthcare workers,['Other'],https://zenodo.org/records/12737228,"[{""question"": ""What is the effect of BCG vaccination on COVID-19 severity when controlling for patient interaction frequency in healthcare workers?"", ""options"": [""Increases severity odds by 24.5%"", ""Decreases severity odds by 52.4%"", ""Increases severity odds by 52.4%"", ""No significant effect on severity""]}, {""question"": ""What is the relationship between healthcare workers' expected patient interaction and COVID-19 severity?"", ""options"": [""Expected interaction has no significant effect on severity"", ""Expected interaction increases severity odds by 24.5%"", ""Expected interaction reduces severity odds by 75.5%"", ""Expected interaction reduces severity odds by 24.5%""]}, {""question"": ""How does the distribution of COVID-19 severity differ among healthcare workers seeing different numbers of patients?"", ""options"": [""Significant difference only in the 1-50 patients group"", ""Significant difference only in the >100 patients group"", ""No significant differences in any patient number group"", ""Significant differences across all patient number groups""]}, {""question"": ""Using a chi-square test, what is the p-value for the association between BCG vaccination and COVID-19 severity among healthcare workers who expect to interact with patients?"", ""options"": [""0.025"", ""0.124"", ""0.048"", ""0.367""]}, {""question"": ""What is the effect of BCG re-vaccination on COVID-19 severity odds among healthcare workers who interact with patients?"", ""options"": [""Decreases severity odds by 34.4%"", ""Has no significant effect on severity odds"", ""Increases severity odds by 34.4%"", ""Decreases severity odds by 24.5%""]}, {""question"": ""For healthcare workers seeing 1-50 patients, what is the statistical significance (p-value) of the association between vaccination status and disease severity?"", ""options"": [""p = 0.052"", ""p = 0.024"", ""p = 0.444"", ""p = 0.327""]}, {""question"": ""How do the odds of higher COVID-19 severity compare between healthcare workers who expect to interact with patients versus those who do not?"", ""options"": [""34.4% lower odds"", ""24.5% lower odds"", ""24.5% higher odds"", ""34.4% higher odds""]}]",CapsuleFolder-fbe0e950-76f2-4eb7-a216-a2d377970922.zip
cd811ead-7887-4369-b175-05aff4223765,bix-11,Fungi have higher treeness values compared to animals.,"['Genomics', 'Phylogenetics and Evolutionary Analysis']",Not Available,"[{""question"": ""What is the magnitude of difference in median treeness values between fungi and animals?"", ""options"": [""0.075"", ""0.015"", ""0.05"", ""0.105""]}, {""question"": ""What percentage of fungal genes show treeness values above 0.06?"", ""options"": [""45%"", ""35%"", ""25%"", ""15%""]}, {""question"": ""What is the treeness value of the most divergent ortholog (highest treeness) in the animal dataset?"", ""options"": [""0.1126"", ""0.1562"", ""0.0884"", ""0.1345""]}, {""question"": ""What is the Mann-Whitney U statistic for the comparison of treeness values between fungi and animals?"", ""options"": [""4891.0"", ""2584.0"", ""1247.5"", ""3556.0""]}, {""question"": ""What is the p-value for the Mann-Whitney U test comparing treeness values between fungi and animals?"", ""options"": [""0.0478"", ""0.0341"", ""0.1205"", ""0.0012""]}, {""question"": ""What is the median treeness value for fungal orthologs?"", ""options"": [""0.0489"", ""0.0612"", ""0.0234"", ""0.0855""]}]",CapsuleFolder-cd811ead-7887-4369-b175-05aff4223765.zip
d38392ec-84b8-485d-ab02-b8788e6f1f43,bix-12,Fungi have a higher number and percentage of parsimony informative sites in their alignments.,"['Genomics', 'Phylogenetics and Evolutionary Analysis', 'Whole Genome Sequencing (WGS)']",Not Available,"[{""question"": ""What does the distribution of parsimony informative sites in fungal proteins suggest about their evolutionary rate compared to animal proteins?"", ""options"": [""Fungal proteins evolve more rapidly than animal proteins"", ""Fungal proteins have identical evolutionary rates to animal proteins"", ""Fungal proteins are more structurally constrained than animal proteins"", ""Fungal proteins show no consistent pattern of evolution""]}, {""question"": ""What is the median percentage of parsimony informative (variable) sites across all single-copy orthologous genes in fungi?"", ""options"": [""3.5%"", ""5.2%"", ""4.9%"", ""1.2%""]}, {""question"": ""What is the ratio of percent parsimony informative (variable) sites between the most conserved fungal gene and the most conserved animal gene in the dataset?"", ""options"": [""3.0"", ""3.0"", ""1.0"", ""0.5""]}, {""question"": ""What is the Mann-Whitney U test value when comparing the percentage of parsimony informative (variable) sites between animals and fungi?"", ""options"": [""6948.0"", ""5891.0"", ""4532.0"", ""7823.0""]}, {""question"": ""What is the maximum number of parsimony informative sites found in any single animal ortholog alignment?"", ""options"": [""29"", ""36"", ""48"", ""24""]}, {""question"": ""What is the Mann-Whitney U test statistic when comparing the number of parsimony informative sites between animal and fungal alignments?"", ""options"": [""4521.0"", ""8932.0"", ""3245.0"", ""6748.0""]}]",CapsuleFolder-d38392ec-84b8-485d-ab02-b8788e6f1f43.zip
1d54e4a7-8b0f-4224-bd31-efcfded0d46c,bix-13,Knocking out either rhlI or lasI impacts the downstream expression of dozens of genes which may be involved in mediating the observed division of labor.,"['RNA-seq', 'Differential Expression Analysis', 'Transcriptomics']",https://doi.org/10.17912/micropub.biology.001326,"[{""question"": ""What percentage of genes differentially expressed in strain JBX97 are exclusively also differentially expressed in strain JBX99, relative to strain JBX1 (logfold cutoff either > 1.5 or < -1.5)?"", ""options"": [""31.8%"", ""0.9%"", ""29.8%"", ""10.6%""]}, {""question"": ""How many genes are uniquely differentially expressed in strain 98 but not in either of strains JBX97 or JBX99, relative to strain JBX1 (logfold cutoff either > 1.5 or < -1.5)?"", ""options"": [""137"", ""464"", ""190"", ""166""]}, {""question"": ""How many genes have a dispersion value below 1e-05 when using DEseq for analysis?"", ""options"": [""7"", ""6"", ""9"", ""8""]}, {""question"": ""Which strain and media condition do replicates not fully cluster together based on pairwise correlation after regularized log transformation of the differential expression analysis results?"", ""options"": [""Strain 1 in MMGluFeMinus"", ""Strain 99 in Succinate"", ""Strain 99 in MMGluFePlus"", ""Strain 1 in MMGluFePlus""]}, {""question"": ""Of all differentially expressed genes (FDR<0.05, logfold cutoff either > 1.5 or < -1.5), what is the total percentage of genes either exclusively affected in \u2206rhlI or \u2206lasI?"", ""options"": [""8.1%"", ""4.8%"", ""15.7%"", ""12.4%""]}, {""question"": ""How many genes are differentially expressed (FDR < 0.05, logfold cutoff either > 1.5 or < -1.5) in at least one of the \u0394lasI or \u0394rhlI single mutants but are not differentially expressed in the \u0394lasI\u0394rhlI double mutant?\n"", ""options"": [""397"", ""512"", ""156"", ""89""]}]",CapsuleFolder-1d54e4a7-8b0f-4224-bd31-efcfded0d46c.zip
7718a922-ce2c-4e59-900b-84fe06050ce6,bix-14,The distribution of variant effects / types of putative somatic CHIP variants in Bloom Syndrome probands and carriers will not differ significantly from that of controls. ,"['Genomics', 'Genomic Variant Analysis']",https://doi.org/10.1172/jci.insight.167744,"[{""question"": ""What mechanism explains the similar distribution of CHIP variant effects between Bloom syndrome patients and controls?"", ""options"": [""BLM helicase preferentially repairs certain variant types"", ""CHIP variants occur independently of BLM function"", ""BLM helicase mutations alter variant effect patterns"", ""BLM helicase affects variant repair frequency but not variant type selection""]}, {""question"": ""What proportion of variants in BLM carriers with VAF < 0.3 are synonymous?"", ""options"": [""0.89"", ""0.13"", ""0.64"", ""0.33""]}, {""question"": ""What is the absolute difference in somatic (VAF < 0.3) missense variant frequency between Control Parents and BSyn Probands?"", ""options"": [""0.333"", ""0.099"", ""0.105"", ""0.228""]}, {""question"": ""How does excluding intronic variants affect the total number of CHIP variants in the dataset?"", ""options"": [""Reduces from 4,550 to 1,234 variants"", ""Reduces from 11,896 to 4,550 variants"", ""Reduces from 57,258 to 4,550 variants"", ""Reduces from 57,258 to 11,896 variants""]}]",CapsuleFolder-7718a922-ce2c-4e59-900b-84fe06050ce6.zip
bda54b38-9b49-4009-aad6-d5f52675438a,bix-16,Genes with higher expression levels are more critical for cancer cell survival and exhibit higher essentiality.,"['Transcriptomics', 'Functional Genomics']",,"[{""question"": ""What gene has the strongest negative Spearman correlation between its expression and essentiality, in the provided data?"", ""options"": [""CCND1"", ""KLF5"", ""CDKN1A"", ""RNASEK""]}, {""question"": ""What is the skewness characteristic of the gene expression (log2(TPM+1)) distribution across all cell lines in the dataset?"", ""options"": [""Right-skewed with a long tail"", ""Symmetrical with no skew"", ""Bimodal with no clear skew"", ""Left-skewed with a long tail""]}, {""question"": ""How many genes in the provided data show strong positive correlation with a Spearman coefficient >= 0.6?"", ""options"": [""5"", ""1"", ""3"", ""0""]}, {""question"": ""Overall, what percentage of genes show a statistically significant correlation between expression and essentiality?"", ""options"": [""7.56%"", ""35.62%"", ""14.25%"", ""21.81%""]}]",CapsuleFolder-bda54b38-9b49-4009-aad6-d5f52675438a.zip
1cf79c8c-fb8c-453c-8788-c8958ab6f152,bix-17,The increased number of somatic variants in CHIP (clonal haematopoiesis of indeterminate potential) genes found in Bloom syndrome probands and carriers is not an effect of increased germline variants in CHIP genes. ,"['Genomics', 'Genomic Variant Analysis']",https://doi.org/10.3324/haematol.2024.285239,"[{""question"": ""What is the correlation coefficient between total CHIP variants and somatic CHIP variants (VAF < 0.3) in the Bloom syndrome proband cohort?"", ""options"": [""0.12"", ""0.45"", ""0.78"", ""0.92""]}, {""question"": ""What is the median number of somatic CHIP variants (VAF < 0.3) in the BLM carrier cohort?"", ""options"": [""2.0"", ""1.0"", ""3.0"", ""4.0""]}, {""question"": ""What is the F-statistic from ANOVA analysis when comparing CHIP variant frequencies between cohorts after removing intronic variants?"", ""options"": [""15.321"", ""42.156"", ""0.863"", ""29.744""]}, {""question"": ""What percentage of total CHIP variants in control parents have VAF < 0.3?"", ""options"": [""5.12%"", ""3.24%"", ""1.57%"", ""0.29%""]}]",CapsuleFolder-1cf79c8c-fb8c-453c-8788-c8958ab6f152.zip
d59734d2-a3e0-462a-a5fd-c8ddc11392b8,bix-18,"Disrupting genes in either the las or rhl quorum sensing (QS) systems, either the receptors or the synthases, abrogates swarming motility, a form of movement that allows Pseudomonas aeruginosa and other bacteria to expand their access to nutrients and therefore increase their fitness.",['Imaging'],https://doi.org/10.17912/micropub.biology.001326,"[{""question"": ""In a P. aeruginosa swarming analysis, what circularity measurement would be most consistent with swarming behavior?"", ""options"": [""0.80"", ""0.32"", ""0.08"", ""1.00""]}, {""question"": ""What is the mean swarming area of wildtype P. aeruginosa?"", ""options"": [""32,000"", ""82,000"", ""92,000"", ""30,000""]}, {""question"": ""What is the approximated reduction in mean colony area for the \u0394lasR mutant compared to wildtype?"", ""options"": [""50% reduction"", ""30% reduction"", ""70% reduction"", ""60% reduction""]}, {""question"": ""What is the standard error of the mean (SEM) for circularity measurements in the rhlR- mutant?"", ""options"": [""0.052"", ""0.012"", ""0.082"", ""0.032""]}, {""question"": ""What is the relative proportion of mean colony area of the \u0394lasR mutant to the wildtype strain?"", ""options"": [""Approximately 50% (1/2) of wildtype"", ""Approximately 25% (1/4) of wildtype"", ""Approximately 75% (3/4) of wildtype"", ""Approximately equal (1/1) to wildtype""]}, {""question"": ""What is the standard error of the mean (SEM) for colony area in the rhlR- mutant strain?"", ""options"": [""0.25"", ""0.35"", ""0.45"", ""0.15""]}]",CapsuleFolder-d59734d2-a3e0-462a-a5fd-c8ddc11392b8.zip
8c64b1fa-fdcc-41e2-be8d-2f0c8d5faaa1,bix-19,Significant neuronal damage is induced by OXTR gene knockdown across rodent species,"['Imaging', 'Other']","https://zenodo.org/records/8036465, https://www.science.org/doi/10.1126/sciadv.adf4950","[{""question"": ""Based on the observed effect size in the NeuN count data, how many samples per group would be required to detect a statistically significant difference between KD and CTRL conditions with 80% power?"", ""options"": [""337 samples"", ""16 samples"", ""167 samples"", ""674 samples""]}, {""question"": ""What is the Cohen's d effect size for the difference in NeuN counts between KD and CTRL conditions in the dataset?"", ""options"": [""0.216"", ""0.668"", ""1.311"", ""0.805""]}, {""question"": ""What is the Shapiro-Wilk test statistic (W) for the KD group's NeuN count distribution?"", ""options"": [""0.723"", ""0.956"", ""0.774"", ""0.951""]}, {""question"": ""What is the F-statistic for the interaction effect between Hemisphere and Sex in the two-way ANOVA analysis?"", ""options"": [""1.066"", ""1.312"", ""3.751"", ""0.192""]}]",CapsuleFolder-8c64b1fa-fdcc-41e2-be8d-2f0c8d5faaa1.zip
2ccdbe37-0a92-47b5-9bab-fa8a8c470799,bix-20,The distribution of variant pathogenicity of putative somatic CHIP variants in Bloom Syndrome probands and carriers will not differ significantly from that of controls.,"['Genomics', 'Genomic Variant Analysis']",doi.org/10.3324/haematol.2024.285239,"[{""question"": ""What proportion of putatively somatic (VAF < 0.3, exonic) CHIP variants in BSyn Probands can be considered benign?"", ""options"": [""0.77"", ""0.65"", ""0.93"", ""0.85""]}, {""question"": ""What is the proportion of likely benign, exonic variants in the Control Children group for variants with VAF < 0.3?"", ""options"": [""0.00"", ""0.10"", ""0.05"", ""0.15""]}, {""question"": ""What is the difference in the proportion of benign exonic variants (VAF < 0.3) between BLM Carriers and BSyn Probands?"", ""options"": [""0.072"", ""0.047"", ""0.025"", ""0.017""]}, {""question"": ""What is the total number of pathogenicity categories observed in BLM Carriers after applying the VAF < 0.3 filter?"", ""options"": [""2"", ""3"", ""1"", ""4""]}, {""question"": ""What is the ratio of benign to likely benign variants in Bloom Syndrome probands for exonic variants with VAF < 0.3?"", ""options"": [""7:1"", ""13:1"", ""19:1"", ""5:1""]}, {""question"": ""What percentage of putative somatic variants (VAF < 0.3, exonic) are classified as benign in BLM carriers?"", ""options"": [""100%"", ""89.3%"", ""92.9%"", ""94.6%""]}, {""question"": ""How does filtering for putative somatic variants (VAF < 0.3, exonic) affect the number of pathogenicity categories observed in control children?"", ""options"": [""Reduces to 0 categories"", ""Increases to 3 categories"", ""Reduces to 1 category"", ""Maintains 2 categories""]}]",CapsuleFolder-2ccdbe37-0a92-47b5-9bab-fa8a8c470799.zip
e3bde22d-915c-409b-8646-039e0215b171,bix-21,Animals will have lower signatures of saturation by multiple substitutions than fungi.,"['Whole Genome Sequencing (WGS)', 'Phylogenetics and Evolutionary Analysis']",Not Available,"[{""question"": ""What rate of saturation accumulation would be expected in a clade of fungi with generation times comparable to animals?"", ""options"": [""No relationship between generation time and saturation rate"", ""Higher than typical fungi due to increased DNA replication errors"", ""Similar to typical fungi due to phylogenetic constraints"", ""Lower than typical fungi due to fewer generations per unit time""]}, {""question"": ""What is the median saturation value for BUSCO genes in the fungi?"", ""options"": [""0.58"", ""0.45"", ""0.71"", ""0.62""]}, {""question"": ""How would including an additional 6 mammalian species affect the average saturation value of the animal dataset?"", ""options"": [""Remain within 5% of the original value"", ""Double the original value"", ""Decrease by approximately 15%"", ""Increase by approximately 15%""]}, {""question"": ""If ribosomal proteins evolve at 1/3 the rate of metabolic enzymes, what would be the expected ratio of saturation values between these two protein classes in fungi?"", ""options"": [""1:9"", ""1:3"", ""1:1"", ""3:1""]}, {""question"": ""What biological feature of animals likely explains their lower saturation values compared to fungi?"", ""options"": [""Greater species diversity"", ""Larger genome sizes"", ""Higher mutation rates"", ""Longer generation times""]}]",CapsuleFolder-e3bde22d-915c-409b-8646-039e0215b171.zip
34a4ea96-c800-4c11-959e-57cdc4932c52,bix-22,Gene length positively correlates with expression level across immune cell types in children,"['RNA-seq', 'Transcriptomics']",https://zenodo.org/records/10000430,"[{""question"": ""What is the magnitude of correlation between gene length and expression in CD4 T cells when examining only genes with expression values above the median?"", ""options"": [""0.05"", ""0.12"", ""0.03"", ""-0.01""]}, {""question"": ""For genes between 1000-2000 base pairs in length, what is the Pearson correlation coefficient between gene length and expression in CD14 cells?"", ""options"": [""0.045"", ""0.035"", ""0.015"", ""0.025""]}, {""question"": ""What is the difference in correlation coefficients between CD19 and CD14 cells when analyzing genes shorter than 5000 base pairs?"", ""options"": [""0.025"", ""0.035"", ""0.005"", ""0.015""]}, {""question"": ""What is the p-value for the correlation between gene length and expression in CD8 T cells when excluding genes in the bottom quartile of expression?"", ""options"": [""1.2 x 10^-8"", ""7.8 x 10^-9"", ""5.5 x 10^-9"", ""3.2 x 10^-8""]}, {""question"": ""What is the Pearson correlation coefficient between gene length and expression level in CD4 T cells?"", ""options"": [""0.435670"", ""0.049889"", ""0.202527"", ""0.356620""]}, {""question"": ""Which immune cell type shows the highest correlation coefficent between gene length and expression level?"", ""options"": [""CD4"", ""CD14"", ""CD8"", ""CD19""]}, {""question"": ""What is the p-value for the correlation between gene length and expression in CD14 cells?"", ""options"": [""1.920290e-06"", ""5.481596e-09"", ""6.140363e-03"", ""2.677958e-11""]}]",CapsuleFolder-34a4ea96-c800-4c11-959e-57cdc4932c52.zip
8690e7cb-7405-4d2a-9721-e85824d05822,bix-23,Insertion and deletion events are more frequent in fungi compared to animals resulting in longer multiple sequence alignment lengths.,"['Whole Genome Sequencing (WGS)', 'Genomic Variant Analysis']",Not Available,"[{""question"": ""What is the percent difference in median gap character between fungal and animal multiple sequence alignments?"", ""options"": [""33% higher in fungi"", ""15% higher in fungi"", ""90% higher in fungi"", ""45% higher in fungi""]}, {""question"": ""What is the median position of the first gap occurrence in fungal BUSCO gene alignments?"", ""options"": [""Position 126"", ""Position 158"", ""Position 47"", ""Position 83""]}, {""question"": ""What is the correlation coefficient (using pearson) between original sequence length and number of gaps in animal BUSCO genes?"", ""options"": [""0.12"", ""0.83"", ""0.48"", ""0.32""]}, {""question"": ""In the animal BUSCO gene alignments, what percentage of alignment positions containing gaps show high sequence conservation (>80% identity) in the non-gap sequences?"", ""options"": [""12%"", ""24%"", ""48%"", ""36%""]}]",CapsuleFolder-8690e7cb-7405-4d2a-9721-e85824d05822.zip
b1b0ef00-cb15-4375-9aac-e1e53a7250c5,bix-24,CBD treatment of CRC cells causes metabolic dysregulation in the cells,"['RNA-seq', 'Differential Expression Analysis', 'Transcriptomics']","https://zenodo.org/records/8353706, https://www.mdpi.com/1422-0067/24/19/14743","[{""question"": ""What specific metabolic pathway enriched in the downregulated DGEs in CBD-treated CRC cells based on enrichment analysis?"", ""options"": [""Amino acid metabolism"", ""Canonical glycolysis"", ""Oxidative phosphorylation"", ""Cellular response to hypoxia""]}, {""question"": ""What is the predominant direction of gene expression change in CBD-treated CRC cells?"", ""options"": [""Upregulation"", ""Downregulation"", ""No significant change in expression"", ""No consistent direction of change""]}, {""question"": ""How does gene expression change between DMSO and CBD-treated cells?"", ""options"": [""Significantly upregulated in CBD-treated cells"", ""No significant difference"", ""Significantly upregulated in DMSO-treated cells"", ""Significantly downregulated in CBD-treated cells""]}, {""question"": ""How does gene expression change between Untreated and DMSO-treated cells?"", ""options"": [""No significant difference"", ""Significantly upregulated in Untreated cells"", ""Significantly upregulated in DMSO-treated cells"", ""Significantly downregulated in DMSO-treated cells""]}, {""question"": ""What evidence from a pathway enrichment analysis of CBD-treated CRC cells supports metabolic dysregulation?"", ""options"": [""Multiple metabolic pathways including glycolysis and glucose catabolism are among the most significantly enriched downregulated processes"", ""A single metabolic pathway appears in the top 20 enriched terms"", ""Metabolic pathways are equally enriched in up- and down-regulated genes"", ""Only glycolysis-related pathways are enriched in downregulated genes""]}, {""question"": ""What biological process shows the most significant enrichment (lowest adjusted p-value) in the CBD treatment setting across/using all genes?"", ""options"": [""Canonical glycolysis"", ""Glycolytic process"", ""Carbohydrate catabolic process"", ""Cellular response to decreased oxygen levels""]}, {""question"": ""How are genes involved in the glycolysis pathway regulated in CBD-treated CRC cells?"", ""options"": [""Predominantly downregulated with genes like GPI, PGK1, and ALDOC"", ""No significant change"", ""Mixed up- and down-regulation"", ""Predominantly upregulated""]}]",CapsuleFolder-b1b0ef00-cb15-4375-9aac-e1e53a7250c5.zip
964b67db-88d8-4286-9995-10ccc6ba4c39,bix-25,Fungi have higher treeness / RCV values compared to animals.,"['Genomics', 'Phylogenetics and Evolutionary Analysis']",Not Available,"[{""question"": ""What is the median treeness/RCV value for fungal genes in the dataset?"", ""options"": [""0.26"", ""0.34"", ""0.45"", ""0.12""]}, {""question"": ""What is the correlation coefficient between gene alignment length and treeness/RCV values in the dataset?"", ""options"": [""0.33"", ""-0.52"", ""0.08"", ""-0.15""]}, {""question"": ""What percentage of single-copy orthologous genes show treeness/RCV values above 0.4 in both animals and fungi?"", ""options"": [""31%"", ""8%"", ""22%"", ""15%""]}, {""question"": ""What is the maximum treeness/RCV value observed in genes with greater than 70% alignment gaps?"", ""options"": [""0.21"", ""0.62"", ""0.35"", ""0.48""]}]",CapsuleFolder-964b67db-88d8-4286-9995-10ccc6ba4c39.zip
0923d260-fe1b-4fb4-4398-79edf546e584,bix-26,Downstream gene expression of rhlI and lasI mutants is altered in different media suggesting that quorum sensing-mediated division of labor is environment-dependent.,"['RNA-seq', 'Transcriptomics', 'Differential Expression Analysis']",https://doi.org/10.17912/micropub.biology.001326,"[{""question"": ""In the iron-depleted glucose medium, what KEGG pathway enrichment pattern, using over-representation analysis (logfold cutoff 1.5 or -1.5, adjusted p-value cutoff 0.05), provides direct evidence for environment-specific bacterial responses?"", ""options"": [""Enrichment of ABC transporters in upregulated genes only"", ""Dual enrichment of sulfur metabolism in both up and downregulated genes"", ""Enrichment of bacterial secretion systems in upregulated genes only"", ""Exclusive enrichment of cyanoamino acid metabolism in downregulated genes""]}, {""question"": ""What is the approximate adjusted p-value for the least significantly enriched KEGG pathway, using over-representation analysis (logfold cutoff 1.5 or -1.5, adjusted p-value cutoff 0.05), in the succinate media condition's upregulated gene set?"", ""options"": [""0.025"", ""0.010"", ""0.020"", ""0.015""]}, {""question"": ""Approximately how many genes contribute to the ABC transporters pathway enrichment in over-representation analysis (logfold cutoff 1.5 or -1.5, adjusted p-value cutoff 0.05) in the iron-depleted glucose condition?"", ""options"": [""10 genes"", ""15 genes"", ""20 genes"", ""25 genes""]}, {""question"": ""How many KEGG pathways, using over-representation analysis (logfold cutoff 1.5 or -1.5, adjusted p-value cutoff 0.05), show significant downregulation in both succinate and iron-depleted glucose media conditions?"", ""options"": [""5 pathways"", ""4 pathways"", ""2 pathways"", ""6 pathways""]}, {""question"": ""In a KEGG pathway enrichment (over-representation) analysis (logfold cutoff 1.5 or -1.5, adjusted p-value cutoff 0.05), of P. aeruginosa gene expression, how many pathways shows significant enrichment specifically in iron-depleted conditions but not in succinate media?"", ""options"": [""5"", ""1"", ""3"", ""6""]}, {""question"": ""What is the number of genes involved in the least significantly enriched pathway (largest significant adjusted p-value) in iron-depleted conditions?"", ""options"": [""8 genes"", ""18 genes"", ""46 genes"", ""24 genes""]}, {""question"": ""What is the adjusted p-value threshold used to determine significant pathway enrichment in the KEGG over-representation analysis?"", ""options"": [""0.1"", ""0.001"", ""0.01"", ""0.05""]}]",CapsuleFolder-0923d260-fe1b-4fb4-4398-79edf546e584.zip
0f14ffa7-f02a-4d20-8142-dfc404195e56,bix-27,"Alzheimerâ€™s disease patients can be subtyped by gene expression, suggesting distinct mechanisms and therapeutic targets.","['RNA-seq', 'Transcriptomics', 'Machine Learning and Artificial Intelligence']",https://doi.org/10.5061/dryad.ttdz08kxq,"[{""question"": ""What is the adjusted rand index (ARI) value when comparing train and test consensus clusters in the experimental dataset with 3 clusters?"", ""options"": [""0.881"", ""1.000"", ""0.042"", ""0.906""]}, {""question"": ""How many samples are consistently classified into the same cluster across both training and test consensus clustering with 3 clusters?"", ""options"": [""173"", ""96"", ""56"", ""178""]}, {""question"": ""What is the predominant biological process enriched in genes specific to cluster 0?"", ""options"": [""Protein degradation"", ""Cell adhesion"", ""Oxidative phosphorylation"", ""Synaptic vesicle transport""]}, {""question"": ""What percentage of genes identified as specific to cluster 1 (using a logistic regression coefficient threshold of 1.5) are associated with druggable targets in ChEMBL?"", ""options"": [""15%"", ""35%"", ""25%"", ""5%""]}, {""question"": ""What adjusted rand index (ARI) value indicates that Alzheimer's disease patient subtypes are more stable than random clustering?"", ""options"": [""ARI > 0.80"", ""ARI > 0.40"", ""ARI > 0.20"", ""ARI > 0.60""]}, {""question"": ""What is the optimal number of clusters for patient stratification based on normalized mutual information (NMI) values?"", ""options"": [""5 clusters (NMI not calculated)"", ""3 clusters (NMI = 0.868)"", ""2 clusters (NMI = 0.805)"", ""4 clusters (NMI = 0.830)""]}, {""question"": ""Which biological pathway characterizes the first identified patient subtype (Cluster 0)?"", ""options"": [""Protein degradation"", ""Oxidative phosphorylation"", ""Synaptic vesicle transport"", ""Cell cycle regulation""]}]",CapsuleFolder-0f14ffa7-f02a-4d20-8142-dfc404195e56.zip
c66d3ed9-0a95-46be-a237-ed68498ea7f6,bix-28,Fungi have greater variation among evolutionary rates than observed among animals.,"['Whole Genome Sequencing (WGS)', 'Genomics', 'Phylogenetics and Evolutionary Analysis']",Not Available,"[{""question"": ""What p-value was obtained when comparing median long branch scores between fungi and animals?"", ""options"": [""3.333 x 10^-25"", ""5.107 x 10^-47"", ""2.811 x 10^-29"", ""1.000 x 10^-15""]}, {""question"": ""What is the median value for fungal mean long branch scores in the dataset?"", ""options"": [""-27.5000"", ""-40.1645"", ""-25.0000"", ""-33.3333""]}, {""question"": ""What is the median long branch score for the BUSCO gene 996662at2759 in fungi?"", ""options"": [""-33.3333"", ""-30.4551"", ""-28.7577"", ""-25.0000""]}, {""question"": ""What is the Mann-Whitney U statistic when comparing mean long branch scores between animals and fungi?"", ""options"": [""4639.0"", ""3265.8"", ""177.0"", ""2553.6""]}, {""question"": ""What is the average median long branch score for fungal sequences?"", ""options"": [""-45.2"", ""-25.0"", ""-26.9"", ""-33.3""]}, {""question"": ""What is the absolute difference in average mean long branch scores between animals and fungi?"", ""options"": [""5.2"", ""1.7"", ""8.3"", ""3.1""]}]",CapsuleFolder-c66d3ed9-0a95-46be-a237-ed68498ea7f6.zip
b8c485ff-d146-4162-9403-9593c8847cfe,bix-29,Prior history of severe disease correlates with increased COVID-19 severity among healthcarre workers following BCG re-vaccination,['Other'],https://zenodo.org/records/12737228,"[{""question"": ""What is the effect of BCG vaccination on COVID-19 severity when controlling for prior medical history count?"", ""options"": [""Decreases severity with odds ratio 0.74"", ""No significant effect (odds ratio ~1.0)"", ""Increases severity with odds ratio 1.63"", ""Decreases severity only in those with multiple prior conditions""]}, {""question"": ""What is the independent effect of each additional ongoing medical condition on COVID-19 severity?"", ""options"": [""35% increase in odds of higher severity"", ""50% increase in odds of higher severity"", ""15% decrease in odds of higher severity"", ""No significant change in severity odds""]}, {""question"": ""How does the interaction between BCG vaccination and prior medical history affect COVID-19 severity?"", ""options"": [""No significant interaction effect (OR\u22481.0)"", ""Strongly antagonistic effect decreasing severity"", ""Strongly synergistic effect increasing severity"", ""Variable effect depending on number of conditions""]}, {""question"": ""What is the impact of patient interaction frequency on COVID-19 severity among healthcare workers?"", ""options"": [""Variable effect depending on vaccination status"", ""Moderate negative correlation with severity"", ""Strong positive correlation with severity"", ""No significant effect on severity (OR\u22481.02)""]}]",CapsuleFolder-b8c485ff-d146-4162-9403-9593c8847cfe.zip
3d4eb7bb-4fbc-4300-b79a-3eba7a6221bc,bix-30,Serum miRNAs can be used as Myotonic Dystrophy Type 1 Biomarkers,"['Transcriptomics', 'Differential Expression Analysis']",10.1371/journal.pone.0150501,"[{""question"": ""What percentage of the analyzed miRNAs show significant differential expression (p \u2264 0.05) before multiple testing correction?"", ""options"": [""42%"", ""35%"", ""15%"", ""28%""]}, {""question"": ""How many miRNAs remain significant at p \u2264 0.05 after Benjamini-Hochberg correction?"", ""options"": [""36"", ""12"", ""24"", ""0""]}, {""question"": ""What is the ratio of significant miRNAs (p \u2264 0.05) identified using Bonferroni correction compared to Benjamini-Yekutieli correction?"", ""options"": [""1:3"", ""0:0"", ""1:2"", ""2:3""]}, {""question"": ""For miR-95, what percentage of control samples contain valid (non-NA) expression measurements?"", ""options"": [""89%"", ""67%"", ""80%"", ""100%""]}, {""question"": ""How many miRNAs maintain statistical significance (p \u2264 0.05) after applying all three methods of multiple testing correction (Benjamini-Hochberg, Benjamini-Yekutieli, and Bonferroni)?"", ""options"": [""18 miRNAs"", ""49 miRNAs"", ""0 miRNAs"", ""175 miRNAs""]}, {""question"": ""What is the effect of log2 transformation on the number of miRNAs showing significant differences (p \u2264 0.05) between patients and controls before multiple testing correction?"", ""options"": [""49 miRNAs show significance"", ""175 miRNAs show significance"", ""25 miRNAs show significance"", ""0 miRNAs show significance""]}, {""question"": ""What is the impact on the statistical analysis when samples P_3 and C_18 are included in the dataset?"", ""options"": [""All miRNAs become significant"", ""No change in the number of significant miRNAs"", ""The number of significant miRNAs increases to 75"", ""The number of significant miRNAs decreases to 35""]}]",CapsuleFolder-3d4eb7bb-4fbc-4300-b79a-3eba7a6221bc.zip
b1dbace7-f6e9-42ec-81e1-bcc24161cc27,bix-31,Sex-specific differences in gene expression are more pronounced in protein-coding genes within CD4 and CD8 cells,"['RNA-seq', 'Differential Expression Analysis', 'Transcriptomics']",https://zenodo.org/records/10000430,"[{""question"": ""What is the t-statistic value when comparing sex-specific differential expression between protein-coding genes in CD4/CD8 cells versus other cell types?"", ""options"": [""6.50"", ""18.93"", ""-0.45"", ""222.38""]}, {""question"": ""By performing a sex-specific differential expression analysis of protein-coding genes, what is the adjusted p-value of FAM138A?"", ""options"": ["">=0.0.5"", ""<0.001"", ""<0.05"", ""NaN""]}, {""question"": ""How many genes show significant differential expression (padj < 0.05, |log2FoldChange| > 0.5) between males and females specifically in CD4/CD8 cells?"", ""options"": [""147"", ""223"", ""197"", ""168""]}, {""question"": ""What is the p-value for the comparison of sex-specific differential expression between protein-coding and non-protein-coding genes in CD4/CD8 cells?"", ""options"": [""1.55e-79"", ""6.50e-01"", ""1.67e-19"", ""6.42e-97""]}, {""question"": ""What is the p-value obtained when comparing log-fold changes between protein-coding and non-protein-coding genes within CD4/CD8 cells?"", ""options"": [""6.50e-01"", ""1.55e-79"", ""1.28e-31"", ""6.42e-97""]}]",CapsuleFolder-b1dbace7-f6e9-42ec-81e1-bcc24161cc27.zip
a94b7008-bb9a-4a46-ebfb-4afdfdd299d5,bix-32,"Knocking out either lasI, rhlI, or both simultaneously, alters the expression of numerous downstream pathways of diverse functions.
","['RNA-seq', 'Transcriptomics', 'Differential Expression Analysis']",https://doi.org/10.17912/micropub.biology.001326,"[{""question"": ""Based on the KEGG enrichment analysis (over-representation analysis), how many distinct functional categories (metabolism, signaling, cellular processes) show significant enrichment (adjusted p-value < 0.05) in upregulated genes (logfold > 1.5) in strain 97 relative to strain 1?"", ""options"": [""6 functional categories"", ""4 functional categories"", ""2 functional categories"", ""1 functional category""]}, {""question"": ""How many metabolic pathways are exclusively significantly enriched (regardless of direction of regulation) in the \u0394lasI\u0394rhlI double mutant (strain 99) but not in either of the single mutants (strain 97 and 98), relative to wildtype (strain 1)?"", ""options"": [""0"", ""7"", ""5"", ""3""]}, {""question"": ""What is the regulatory direction of biofilm formation pathway genes in the \u0394lasI mutant (strain 98) relative to wildtype (strain 1), using KEGG enrichment (over-representation analysis)?"", ""options"": [""No significant change"", ""Both up and downregulated"", ""Exclusively upregulated"", ""Exclusively downregulated""]}, {""question"": ""How many enriched pathways using KEGG enrichment (over-representation analysis) are significantly enriched in all three mutant strains (97, 98, and 99), relative to wildtype (strain 1), in the same direction (either upregulated or downregulated)?"", ""options"": [""0 pathways"", ""4 pathways"", ""6 pathways"", ""2 pathways""]}, {""question"": ""In a KEGG pathway enrichment over-representation analysis (adjusted p-value < 0.05, and logfold > 1.5) of quorum sensing mutants, what two functional categories are exclusively upregulated in the double knockout strain 99 (\u0394lasI\u0394rhlI) strain and not in the single knockouts (strains 97 and 98), relative to wildtype (strain 1)?"", ""options"": [""Sulfur metabolism, quorum sensing"", ""Ribosome, riboflavin metabolism"", ""Starch and sucrose metabolism, two-component system"", ""Nitrogen metabolism, two-component system""]}, {""question"": ""What two cellular process pathways show consistent enrichment using KEGG over-representation analysis (adjusted p-value < 0.05) across all three quorum sensing mutant strains (97, 98, 99), relative to wildtype (strain 1)?"", ""options"": [""Sulfur metabolism, phenazine biosynthesis"", ""Biosynthesis of secondary metabolites, nitrogen cycle"", ""Two-component system, ribosome"", ""Fatty acid metabolism, two-component system""]}, {""question"": ""Which metabolic pathway shows the least significant enrichment (highest p.adjust value) in the \u0394lasI (strain #98), relative to wildtype (strain 1), mutant in KEGG over-representation analysis?"", ""options"": [""Nitrogen metabolism"", ""Carbon metabolism"", ""Valine, leucine and isoleucine degradation"", ""Butanoate metabolism""]}]",CapsuleFolder-a94b7008-bb9a-4a46-ebfb-4afdfdd299d5.zip
a5fba1a0-ad42-41da-a299-201655a5ffe8,bix-33,AAV9 mini-dystrophin treatment leads to a downregulation of anti-inflammatory pathways in peripheral immune cells,"['Single-Cell Analysis', 'Differential Expression Analysis']",https://doi.org/10.5281/zenodo.13935259,"[{""question"": ""By performing a gene expression analysis of peripheral immune cells, what conclusion can be drawn about the hypothesis that AAV9 mini-dystrophin treatment leads to downregulation of anti-inflammatory pathways?"", ""options"": [""The hypothesis is partially supported with mixed effects across different cell types"", ""The hypothesis is strongly supported with significant downregulation of multiple anti-inflammatory genes"", ""The hypothesis cannot be evaluated due to insufficient data"", ""The hypothesis is not supported as no significant downregulation of anti-inflammatory pathways was observed""]}, {""question"": ""Which immune cell type showed the most significant changes in gene expression following AAV9 mini-dystrophin treatment?"", ""options"": [""Plasmacytoid dendritic cells"", ""Natural Killer cells"", ""CD14 Monocytes"", ""Regulatory T cells (Tregs)""]}, {""question"": ""What pattern was observed in the expression of key anti-inflammatory genes following treatment?"", ""options"": [""Variable expression with both up and downregulation"", ""No significant changes in expression"", ""Uniform downregulation across all cell types"", ""Selective upregulation in CD14 monocytes only""]}, {""question"": ""What did the pathway analysis reveal about inflammatory responses in immune cells after treatment?"", ""options"": [""Activation of inflammatory response in specific cell types"", ""Global downregulation of immune responses"", ""Complete suppression of inflammatory pathways"", ""No significant changes in inflammatory pathways""]}, {""question"": ""What is the direction of change for IL10 expression in CD14 monocytes after treatment?"", ""options"": [""No significant change"", ""Significant upregulation (log2FC = 0.87)"", ""Significant downregulation"", ""Significant upregulation (log2FC = 0.35)""]}, {""question"": ""How many peripheral immune cell types show significant differential expression (adjusted p-value < 0.05) of SOCS3?"", ""options"": [""4"", ""2"", ""3"", ""1""]}, {""question"": ""Using GSEA, which cell type shows most significant enrichment of the GO biological process term 'inflammatory response'?"", ""options"": [""CD16 Monocytes (p < 0.05)"", ""pDCs (not significant)"", ""CD14 Monocytes (p < 0.0001)"", ""Tregs (p < 0.01)""]}]",CapsuleFolder-a5fba1a0-ad42-41da-a299-201655a5ffe8.zip
17baa727-5eb7-4544-a466-3148a48b3cde,bix-34,Patristic distances in greater in animals compared to fungi.,"['Whole Genome Sequencing (WGS)', 'Genomics', 'Phylogenetics and Evolutionary Analysis']",Not Available,"[{""question"": ""What is the average mean patristic distance for fungal genes in the dataset?"", ""options"": [""1.23"", ""1.67"", ""0.85"", ""2.15""]}, {""question"": ""What is the median patristic distance for the gene 981902at2759 in fungi?"", ""options"": [""2.72"", ""2.63"", ""1.98"", ""2.12""]}, {""question"": ""What is the U-statistic value from the Mann-Whitney U test comparing mean patristic distances between animals and fungi?"", ""options"": [""1035.9"", ""2471.6"", ""3516.0"", ""6211.0""]}, {""question"": ""What is the difference between the highest and lowest mean patristic distances among animal genes in the dataset?"", ""options"": [""1.75"", ""0.95"", ""2.15"", ""1.94""]}, {""question"": ""What is the ratio of the median mean patristic distances between fungi and animals for orthologous genes?"", ""options"": [""2.25"", ""1.25"", ""1.95"", ""0.75""]}, {""question"": ""What is the average mean patristic distance among orthologous genes in the animal dataset?"", ""options"": [""1.23"", ""0.91"", ""1.56"", ""0.52""]}]",CapsuleFolder-17baa727-5eb7-4544-a466-3148a48b3cde.zip
4cb6f8ce-4d81-40b2-8d9c-85868796ee73,bix-35,Fungi are evolving faster than animals.,"['Whole Genome Sequencing (WGS)', 'Genomics', 'Phylogenetics and Evolutionary Analysis']",Not Available,"[{""question"": ""What pattern in the phylogenetic tree branch lengths would provide direct evidence for accelerated evolution in fungi compared to animals?"", ""options"": [""Equal branch lengths between fungi and animals"", ""Longer average branch lengths in fungal trees"", ""Shorter average branch lengths in fungal trees"", ""Variable branch lengths within each group""]}, {""question"": ""When analyzing the BUSCO gene 156083at2759 across the study species, what is its evolutionary rate value in animals?"", ""options"": [""0.5202"", ""0.8489"", ""0.0471"", ""0.9882""]}, {""question"": ""What is the Mann-Whitney U statistic value for the comparison of evolutionary rates between animals and fungi?"", ""options"": [""0.0471"", ""0.6439"", ""3661"", ""1.5224""]}, {""question"": ""What is the highest evolutionary rate observed among all fungal BUSCO genes in the dataset?"", ""options"": [""1.2103"", ""1.3665"", ""0.9918"", ""1.8921""]}, {""question"": ""What is the difference in median evolutionary rate between fungi and animals?"", ""options"": [""0.55"", ""0.45"", ""0.35"", ""0.15""]}]",CapsuleFolder-4cb6f8ce-4d81-40b2-8d9c-85868796ee73.zip
48181cce-3928-4491-94b4-c23504a6aaa1,bix-36,miRNAs exhibit a constant expression profile across immune-related cell types,"['Differential Expression Analysis', 'Transcriptomics', 'RNA-seq']",https://zenodo.org/records/10000430,"[{""question"": ""What F-statistic value from the ANOVA test would indicate strong support for constant miRNA expression across immune cell types?"", ""options"": [""F = 8.4"", ""F = 3.1"", ""F = 5.2"", ""F = 0.77""]}, {""question"": ""How are the log2 fold changes of the CD4 vs CD8 comparison distributed?"", ""options"": [""Left-skewed"", ""Right-skewed"", ""Approximately normal"", ""Bimodal""]}, {""question"": ""What is the median log2 fold change between CD14 and CD19 cell types for miRNAs?"", ""options"": [""Greater than 2.0"", ""Between 0.5 and 1.0"", ""Between 1.0 and 2.0"", ""Close to 0""]}, {""question"": ""What p-value from the multi-group comparison provides evidence for constant miRNA expression?"", ""options"": [""p = 0.001"", ""p = 0.10"", ""p = 0.05"", ""p = 0.57""]}, {""question"": ""What distribution pattern do the log2 fold changes exhibit across all cell type comparisons?"", ""options"": [""Skewed"", ""Uniform"", ""Bimodal"", ""Normal""]}]",CapsuleFolder-48181cce-3928-4491-94b4-c23504a6aaa1.zip
40cbef03-b5c3-4448-b00f-0ba2965dea9b,bix-37,"Proteomics levels of ENO1 are different between tumour and control, in human bladder cancer","['Differential Expression Analysis', 'RNA-seq', 'Proteomics']",10.17632/dj4sb8h3c3.1,"[{""question"": ""What statistical evidence from the proteomics data exists for the hypothesized role of ENO1 in bladder cancer?"", ""options"": [""ENO1 shows no expression in tumor samples"", ""ENO1 shows a log2FC of 2.27 but adjusted p-value of 0.226"", ""ENO1 shows significant downregulation with adjusted p-value < 0.05"", ""ENO1 shows no detectable protein levels in either condition""]}, {""question"": ""How does the adjusted p-value threshold of 0.05 affect the interpretation of ENO1's differential expression status?"", ""options"": [""ENO1's expression is too low to calculate meaningful p-values"", ""ENO1's raw p-value of 0.031 passes the threshold but adjusted p-value of 0.226 does not"", ""Both raw and adjusted p-values pass the significance threshold"", ""Neither raw nor adjusted p-values are calculable for ENO1""]}, {""question"": ""Based on the proteomics data, what is the fold change magnitude of ENO1 expression between tumor and normal samples?"", ""options"": [""4.81-fold increase in tumor"", ""0.031-fold decrease in tumor"", ""2.27-fold increase in tumor"", ""0.226-fold decrease in tumor""]}, {""question"": ""What is the base protein levels of ENO1 in normal samples according to the proteomic data?"", ""options"": [""350,385,456 units"", ""4.81 units"", ""72,896,133 units"", ""2,023 units""]}, {""question"": ""What is the adjusted p-value for ENO1's differential protein abundance/levels between tumor and normal samples?"", ""options"": [""0.226"", ""0.031"", ""4.81"", ""2.27""]}, {""question"": ""What is the log2 fold change value for ENO1 in tumor samples compared to normal samples?"", ""options"": [""0.226"", ""-2.27"", ""2.27"", ""4.81""]}]",CapsuleFolder-40cbef03-b5c3-4448-b00f-0ba2965dea9b.zip
975f3e91-53b0-44b1-ac9f-20023d9c8cd0,bix-38,Single-gene phylogenetic tree lengths are longer in fungi compared to animals.,"['Whole Genome Sequencing (WGS)', 'Genomics', 'Phylogenetics and Evolutionary Analysis']",Not Available,"[{""question"": ""What is the magnitude of difference in median tree length values between fungi and animals for single-copy orthologs?"", ""options"": [""3x larger in fungi"", ""4x larger in fungi"", ""2x larger in fungi"", ""0.5x larger in fungi""]}, {""question"": ""What is the variance in tree length values among animal single-copy orthologs?"", ""options"": [""0.55"", ""1.00"", ""0.25"", ""0.70""]}, {""question"": ""What percentage of fungal single-copy orthologs have tree lengths greater than 5.0?"", ""options"": [""12%"", ""2%"", ""8%"", ""5%""]}, {""question"": ""What is the p-value for the difference in tree length distributions between yeasts and filamentous fungi?"", ""options"": [""0.01"", ""0.05"", ""0.001"", ""0.0001""]}, {""question"": ""What percentage of orthologous genes in fungi show longer tree lengths compared to the mean tree length in animals?"", ""options"": [""45%"", ""65%"", ""94%"", ""32%""]}, {""question"": ""What is the median tree length ratio between fungal and animal orthologs?"", ""options"": [""2.8"", ""1.2"", ""2.1"", ""3.4""]}]",CapsuleFolder-975f3e91-53b0-44b1-ac9f-20023d9c8cd0.zip
28a5984e-9061-4d6f-99a1-40f8753bc9f4,bix-39,"Bloom Syndrome (BSyn) probands and BLM mutation carriers will have a higher number of low-frequency, somatic CHIP gene variants (VAF < 0.3) compared to control cohorts, given that Bloom Syndrome is characterized by increased genomic instability.","['Genomics', 'Genomic Variant Analysis']",https://doi.org/10.3324/haematol.2024.285239,"[{""question"": ""What is the fold difference in median somatic CHIP variant frequency between BLM carriers and control parents?"", ""options"": [""No significant difference"", ""5-fold increase"", ""Infinite (cannot be calculated)"", ""2-fold increase""]}, {""question"": ""What is the interquartile range of somatic CHIP variant counts in BLM carriers?"", ""options"": [""1.5"", ""4.0"", ""3.5"", ""2.5""]}, {""question"": ""How many CHIP variants are filtered out when applying the VAF < 0.3 threshold to the BLM carrier cohort?"", ""options"": [""35 variants"", ""28 variants"", ""51 variants"", ""42 variants""]}, {""question"": ""What percentage of initial CHIP variants are retained after filtering for exonic regions in the control parent cohort?"", ""options"": [""38%"", ""45%"", ""52%"", ""41%""]}]",CapsuleFolder-28a5984e-9061-4d6f-99a1-40f8753bc9f4.zip
d36654ed-2cd6-41c1-84f9-1a3a16be3de5,bix-40,Fungi have a higher number and percentage of variable sites in their alignments compared to animals.,"['Whole Genome Sequencing (WGS)', 'Phylogenetics and Evolutionary Analysis']",Not Available,"[{""question"": ""What percentage of BUSCO genes show zero variable sites in animal alignments compared to fungal alignments?"", ""options"": [""97% in animals vs 49% in fungi"", ""50% in animals vs 50% in fungi"", ""95% in animals vs 5% in fungi"", ""15% in animals vs 85% in fungi""]}, {""question"": ""What is the median number of variable sites per BUSCO gene alignment in fungal species?"", ""options"": [""19 sites"", ""12 sites"", ""35 sites"", ""44 sites""]}, {""question"": ""What percentage of fungal BUSCO genes show greater than 3.8% variable sites in their alignments?"", ""options"": [""25%"", ""15%"", ""45%"", ""50%""]}, {""question"": ""What is the BUSCO gene ID showing the highest percentage of variable sites among all animal alignments?"", ""options"": [""1193442at2759"", ""1620056at2759"", ""1194797at2759"", ""1014314at2759""]}, {""question"": ""What percentage of animal orthologous genes contain zero variable sites?"", ""options"": [""90%"", ""50%"", ""75%"", ""25%""]}, {""question"": ""What is the absolute difference in variable sites between animals and fungi for ortholog 1014314at2759?"", ""options"": [""9 sites"", ""27 sites"", ""15 sites"", ""21 sites""]}]",CapsuleFolder-d36654ed-2cd6-41c1-84f9-1a3a16be3de5.zip
8b462015-86ab-434f-29e1-04dda1588031,bix-41,"Co-culturing the strains with single-gene knockouts (Î”rhlI and Î”lasI) in the reciprocal QS pathways rhl and las, restores wildtype swarming behavior for the population as a whole, albeit in a density-dependent manner.",['Imaging'],https://doi.org/10.17912/micropub.biology.001326,"[{""question"": ""According to Dunnett's test comparing co-culture groups to the wild-type, at the significance threshold of 0.05, which of the following ratios of \u0394rhlI:\u0394lasI co-culture failed to demonstrate statistical equivalence to wild-type in both area and circularity measurements? (\u0394rhlI is Strain 287; \u0394lasI is Strain 98;  wild-type is Strain 1)"", ""options"": [""5:1"", ""10:1"", ""3:1"", ""2:1""]}, {""question"": ""What is the p-value threshold that defines statistical significance for the difference in colony area between co-culture conditions and wild-type in the analysis?"", ""options"": [""0.01"", ""0.1"", ""0.001"", ""0.05""]}, {""question"": ""What is the mean difference in circularity between the \u0394lasI mutant (Strain 98) and the wild-type (Strain 1)?"", ""options"": [""0.73"", ""0.43"", ""0.53"", ""0.63""]}, {""question"": ""How many different co-culture ratios demonstrate significant differences from wild-type (Strain 1) in both area and circularity measurements?"", ""options"": [""6"", ""7"", ""5"", ""4""]}, {""question"": ""At what ratio of \u0394rhlI:\u0394lasI does swarming behavior most closely match wildtype phenotype based on the means for both area and circularity measurements?"", ""options"": [""1:1"", ""5:1"", ""3:1"", ""10:1""]}]",CapsuleFolder-8b462015-86ab-434f-29e1-04dda1588031.zip
27821d45-94e6-4f4e-a914-e66ffaefdd3f,bix-42,Multimodal integration of RNA expression data and DNA methylation data improves the accuracy of colon cancer survival prediction compared to single-modality models.,"['Machine Learning and Artificial Intelligence', 'Integrative Omics', 'Transcriptomics', 'Genomics', 'Other']",https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0305268,"[{""question"": ""How many patients in the provided dataset can be used for survival prediction using integrated RNA expression and DNA methylation data?"", ""options"": [""447"", ""328"", ""267"", ""39""]}, {""question"": ""What is the skewness of the distribution of RNA expression data?"", ""options"": [""Normally distributed"", ""Highly left-skewed"", ""Minimally right-skewed"", ""Highly right-skewed""]}, {""question"": ""Which dataset (Methylation or Expression), or their integration, demonstrates the strongest predictive power for patient survival among those provided?"", ""options"": [""RNA Expression"", ""Equal between Methylation and Expression"", ""DNA Methylation"", ""Integrated Methylation and Expression""]}]",CapsuleFolder-27821d45-94e6-4f4e-a914-e66ffaefdd3f.zip
15ff11e5-2db1-45b6-b3a3-46bc2a74b821,bix-43,combination treatment of CBD and chemotheraputics of CRC cells enriches for cell cycle regulation and apoptosis processes,"['RNA-seq', 'Differential Expression Analysis', 'Transcriptomics']","https://zenodo.org/records/8353706, https://www.mdpi.com/1422-0067/24/19/14743","[{""question"": ""When comparing CBD/cisplatin combination treatment to DMSO control, which cellular process shows the strongest statistical significance in a GO Biological Process enrichment analysis?"", ""options"": [""Fatty acid metabolism"", ""mRNA processing"", ""Immune system response"", ""Negative regulation of epithelial cell proliferation""]}, {""question"": ""What is the odds ratio for p53-mediated cell cycle gene regulation when performing a Reactome pathway analysis of CBD/cisplatin combination treatment?"", ""options"": [""9.45"", ""6.02"", ""4.86"", ""15.34""]}, {""question"": ""How many genes show significant differential expression (padj < 0.05, |log2FoldChange| > 0.5) in the CBD/cisplatin combination treatment compared to DMSO control?"", ""options"": [""955"", ""1761"", ""2757"", ""679""]}, {""question"": ""What proportion of regulated genes in the CBD/cisplatin treatment contribute to the enrichment of p53-regulated cell cycle process identified in the Reactome pathway analysis?"", ""options"": [""8/49"", ""6/44"", ""4/17"", ""3/9""]}, {""question"": ""What is the primary cellular mechanism enriched in the CBD/cisplatin combination treatment according to pathway analysis?"", ""options"": [""Immune system activation"", ""Cell adhesion and matrix organization"", ""Metabolic pathway regulation"", ""p53-mediated cell cycle regulation""]}, {""question"": ""What is the adjusted p-value for enrichment of cytoskeleton organization processes in the enrichment analysis?"", ""options"": [""0.103838"", ""0.399388"", ""0.261997"", ""0.231793""]}, {""question"": ""How many differentially regulated genes contribute to the the p53-mediated cell cycle regulation pathway enrichment?\n"", ""options"": [""10"", ""8"", ""6"", ""5""]}]",CapsuleFolder-15ff11e5-2db1-45b6-b3a3-46bc2a74b821.zip
2ed9023e-75d7-40fe-a425-b6b84ac8329c,bix-44,Fungi have a higher number of sites with compositional bias compared to animals. ,"['Whole Genome Sequencing (WGS)', 'Phylogenetics and Evolutionary Analysis', 'Genomics']",Not Available,"[{""question"": ""What is the median compositional bias value for fungal protein sequences in the analyzed BUSCO gene alignments?"", ""options"": [""-0.2"", ""0.42"", ""0.0"", ""0.15""]}, {""question"": ""What percentage of alignment sites in animal BUSCO genes show compositional bias values above 0.4?"", ""options"": [""22%"", ""35%"", ""15%"", ""8%""]}, {""question"": ""How many individual alignment sites in fungal BUSCO genes demonstrate compositional bias values exceeding 0.75?"", ""options"": [""7,615"", ""9,980"", ""2,845"", ""5,230""]}]",CapsuleFolder-2ed9023e-75d7-40fe-a425-b6b84ac8329c.zip
ebc7c8a6-ba34-46db-bf8c-b3e310434ba9,bix-45,Animals will have lower compositional biases than fungi.,"['Whole Genome Sequencing (WGS)', 'Genomics']",Not Available,"[{""question"": ""Based on the average relative compositional variability (RCV) across orthologous genes, what is the relationship between animals and fungi compositional biases?"", ""options"": [""There are no statistical differences between animals and fungi RCV values, indicating no compositional biases."", ""Fungi and animals both have high RCV values, indicating equal compositional biases."", ""Animals have a lower average RCV value compared to fungi, indicating lower compositional biases."", ""Fungi have lower RCV values compared to animals, indicating lower compositional biases.""]}, {""question"": ""What is the median RCV score for fungal orthologs in the dataset?"", ""options"": [""0.22"", ""0.32"", ""0.27"", ""0.15""]}, {""question"": ""What percentage of orthologous genes show an RCV score above 0.25 in the animal dataset?"", ""options"": [""7%"", ""12%"", ""39%"", ""24%""]}, {""question"": ""What is the effect size (calculated as difference in medians divided by pooled standard deviation) of the RCV score difference between animals and fungi?"", ""options"": [""-0.62"", ""-0.22"", ""0.42"", ""0.32""]}, {""question"": ""What is the median RCV value difference between animals and fungi?"", ""options"": [""0.12"", ""0.15"", ""0.05"", ""0.20""]}, {""question"": ""What is the 75th percentile RCV value for fungal orthologous genes?"", ""options"": [""0.18"", ""0.27"", ""0.24"", ""0.32""]}]",CapsuleFolder-ebc7c8a6-ba34-46db-bf8c-b3e310434ba9.zip
d37acffb-d802-4ce0-8caa-66f50667367a,bix-46,Genes that are downregulated in either Î”rhlI or Î”lasI strains are candidates for receiving complementation from the other strain and are therefore important candidates for mediating division of labor.,"['RNA-seq', 'Differential Expression Analysis', 'Transcriptomics']",https://doi.org/10.17912/micropub.biology.001326,"[{""question"": ""What expression pattern in the mexGHI operon genes would suggest they were promising candidates for mediating division of labor between \u0394rhlI (strain #97) and \u0394lasI (strain #98) strains?"", ""options"": [""Strong upregulation in \u0394rhlI (strain #97) and downregulation in \u0394lasI (strain #98)"", ""No significant change in either strain"", ""Strong downregulation in \u0394rhlI (strain #97) and no change/upregulaton in \u0394lasI (strain #98)"", ""Equal downregulation in both strains""]}, {""question"": ""What is the log2 fold change value for mexG expression in \u0394rhlI (strain #97) compared to wt (strain #1)?"", ""options"": [""-2.09"", ""-4.01"", ""-4.96"", ""-5.45""]}, {""question"": ""How many genes with a log2 fold ratio lower than -4 show significant differential expression (padj < 0.05) exclusively in \u0394lasI (strain #98) but not in \u0394rhlI (strain #97)?"", ""options"": [""35"", ""45"", ""15"", ""8""]}, {""question"": ""Based on differential expression analysis of \u0394rhlI (strain #97) vs. wt (strain #1), which metabolic pathway is most strongly down regulated in \u0394rhlI (strain #97)?"", ""options"": [""Quorum sensing"", ""Rhamnolipid production"", ""Biofilm formation"", ""Phenazine biosynthesis""]}, {""question"": ""How many genes show significant downregulation, at a log2 fold change lower than -5, exclusively in \u0394rhlI (strain #97)?"", ""options"": [""8"", ""5"", ""8"", ""12""]}, {""question"": ""What is the log2 fold change value for the phenazine pathway gene PA14_35160 in the \u0394rhlI mutant?"", ""options"": [""-4.10"", ""-2.85"", ""-0.62"", ""-1.95""]}]",CapsuleFolder-d37acffb-d802-4ce0-8caa-66f50667367a.zip
4a336d0c-3d6b-440a-bfb0-437b26a00af3,bix-47,"We hypothesize that the gene distribution of putative somatic CHIP variants are not significantly different across individuals with or without mutations in the BLM gene (i.e. Bloom syndrome probands, carriers, and controls).","['Genomics', 'Genomic Variant Analysis']",doi.org/10.3324/haematol.2024.285239,"[{""question"": ""How does the distribution of somatic CHIP variants change across individuals with or without mutations in the BLM gene?"", ""options"": [""It is significantly higher in individuals with mutations in the BLM gene"", ""It doesn't change significantly"", ""It is significantly higher in individuals without mutations in the BLM gene"", ""No CHIP variants are present in the population""]}, {""question"": ""What is the name of the gene showing the highest number of CHIP variants across all samples?"", ""options"": [""P502"", ""P557"", ""SRR5566591"", ""P184""]}, {""question"": ""In the hierarchical clustering analysis, what is the cophenetic correlation coefficient between the gene clustering and the original distance matrix?"", ""options"": [""0.82"", ""0.75"", ""0.91"", ""0.67""]}, {""question"": ""What is the ratio of missense to nonsense variants in CHIP genes among control children samples?"", ""options"": [""4.7:1"", ""5.9:1"", ""3.4:1"", ""2.1:1""]}]",CapsuleFolder-4a336d0c-3d6b-440a-bfb0-437b26a00af3.zip
a45810bb-beee-466a-b31f-ba60268afa53,bix-48,Fungi have faster evolutionary rates compared to animals.,"['Genomics', 'Phylogenetics and Evolutionary Analysis']",Not Available,"[{""question"": ""Using the average mean pairwise identity values from single-copy orthologous genes, what is the statistical relationship between evolutionary rates in animals and fungi?"", ""options"": [""Animals evolve 1.5x faster than fungi with p < 0.0001"", ""No significant difference exists between animal and fungal evolutionary rates"", ""Animals evolve 2.5x faster than fungi with p < 0.0001"", ""Fungi evolve 1.5x faster than animals with p < 0.0001""]}, {""question"": ""What is the distribution pattern of median evolutionary rates across single-copy orthologous genes in animals?"", ""options"": [""Right-skewed distribution with median 0.46 pairwise identity"", ""Left-skewed distribution with median 0.55 pairwise identity"", ""Bimodal distribution with peaks at 0.3 and 0.7 pairwise identity"", ""Normal distribution centered at 0.47 pairwise identity""]}, {""question"": ""What is the ratio of standard deviation medians in evolutionary rates between animals and fungi?"", ""options"": [""Animals show 2.5x higher standard deviation than fungi"", ""Animals show 3.5x higher standard deviation than fungi"", ""Fungi show 1.5x higher standard deviation than animals"", ""Animals show 1.2x higher standard deviation than fungi""]}, {""question"": ""What proportion of single-copy orthologous genes show faster median evolutionary rates in animals compared to the median fungi evolutionary rate?"", ""options"": [""45% of genes have a higher median evolutionary rate in animals"", ""33% of genes have a higher median evolutionary rate in animals"", ""72% of genes have a higher median evolutionary rate in animals"", ""63% of genes have a higher median evolutionary rate in animals""]}, {""question"": ""What is the average mean evolutionary rate for fungal species based on pairwise sequence identities?"", ""options"": [""0.68"", ""0.54"", ""0.32"", ""0.39""]}, {""question"": ""What is the difference in average median evolutionary rates between animals and fungi?"", ""options"": [""0.09"", ""0.36"", ""0.24"", ""0.48""]}, {""question"": ""What is the average standard deviation of evolutionary rates among fungal species?"", ""options"": [""0.09"", ""0.21"", ""0.15"", ""0.28""]}]",CapsuleFolder-a45810bb-beee-466a-b31f-ba60268afa53.zip
4ef3fcd8-1c35-466f-9d93-49b92f4ea760,bix-49,"Truncating ASXL1 mutations that cause Bohring-Opitz syndrome will lead to significant dysregulation of gene expression in blood RNA-seq, with a higher number of differentially expressed genes (DEGs) compared to fibroblast RNA-seq due to the complex cellular composition of blood.","['RNA-seq', 'Differential Expression Analysis', 'Transcriptomics']",https://doi.org/10.1172/jci.insight.167744,"[{""question"": ""What is the ratio of blood-specific DEGs to fibroblast-specific DEGs in the ASXL1 mutation analysis?"", ""options"": [""15:1"", ""8:1"", ""12:1"", ""6:1""]}, {""question"": ""What is the maximum log2 fold change observed among statistically significant DEGs in the blood RNA-seq analysis, after adjusting the differential gene expression model with the available metadata?"", ""options"": [""4.21"", ""3.30"", ""3.82"", ""2.87""]}, {""question"": ""What is the adjusted p-value of GRIK5 when performing differential expression analysis on the blood RNA-seq dataset?"", ""options"": [""8.44e-07"", ""7.04e-26"", ""1.42e-05"", ""8.93e-10""]}, {""question"": ""How many genes show a positive log2 fold change (upregulation) among the significant (padj < 0.05) DEGs in the blood RNA-seq analysis?"", ""options"": [""1054"", ""2118"", ""952"", ""833""]}, {""question"": ""What is the total number of significantly dysregulated genes (padj < 0.05) identified in the blood RNA-seq analysis?"", ""options"": [""1106"", ""1766"", ""472"", ""177""]}, {""question"": ""What is the log2 fold change value for the GRIK5 gene in the differential expression analysis?"", ""options"": [""4.803"", ""2.871"", ""4.089"", ""3.458""]}]",CapsuleFolder-4ef3fcd8-1c35-466f-9d93-49b92f4ea760.zip
d49cde68-cc3a-479d-88cb-11302207ac3c,bix-50,The site-wise evolutionary rates in fungi will be faster than those of animals.,"['Whole Genome Sequencing (WGS)', 'Phylogenetics and Evolutionary Analysis']",Not Available,"[{""question"": ""What is the median evolutionary rate per site, as measured by compositional bias, in fungal proteomes compared to animal proteomes?"", ""options"": [""0.36 in fungi vs 0.0 in animals"", ""0.45 in fungi vs 0.25 in animals"", ""0.28 in fungi vs 0.32 in animals"", ""0.25 in fungi vs 0.45 in animals""]}, {""question"": ""What percentage of sites in fungal proteomes show evolutionary rates above 0.4?"", ""options"": [""25%"", ""15%"", ""45%"", ""35%""]}, {""question"": ""How many rapidly evolving sites (compositional bias > 0.5) are present in animal proteomes?"", ""options"": [""5,000 sites"", ""10,000 sites"", ""7,500 sites"", ""2,500 sites""]}, {""question"": ""What is the Mann-Whitney U test statistic when comparing evolutionary rates between animal and fungal proteomes?"", ""options"": [""5,492,955,849.5"", ""6,492,955,849.5"", ""7,492,955,849.5"", ""8,492,955,849.5""]}]",CapsuleFolder-d49cde68-cc3a-479d-88cb-11302207ac3c.zip
93f63fb8-b56c-4ad1-8d3b-d651e2107423,bix-51,"Patient demographics (age, BMI, gender) significantly influence the likelihood of achieving remission (CR/PR) with camrelizumab in advanced hepatocellular carcinoma",['Other'],Not Available,"[{""question"": ""Using a logistic regression model, with age, BMI and gender as predictors (combined model) what is the predicted probability of achieving remission (CR/PR) with camrelizumab treatment in patients aged 65-75?"", ""options"": [""0.25-0.35"", ""0.65-0.75"", ""0.15-0.25"", ""0.45-0.55""]}, {""question"": ""What is the AIC value for the logistic regression model containing only BMI as a predictor?"", ""options"": [""105.16"", ""111.81"", ""104.14"", ""114.85""]}, {""question"": ""What is the p-value for the effect of age in the logistic regression model that uses age, BMI, and gender as predictors (combined model)?"", ""options"": [""0.0021"", ""0.2624"", ""0.0025"", ""0.1363""]}, {""question"": ""What is the change in log-odds of remission for each year increase in patient age, when using the combined model?"", ""options"": [""-0.07495"", ""-0.07951"", ""0.16212"", ""-0.61320""]}, {""question"": ""What is the p-value for BMI as an individual predictor of camrelizumab treatment response in a simple logistic regression model?"", ""options"": [""0.1363"", ""0.0865"", ""0.9588"", ""0.0025""]}, {""question"": ""What is the AIC value for the logistic regression model using only age as a predictor of camrelizumab treatment response?"", ""options"": [""111.81"", ""105.16"", ""114.85"", ""104.14""]}]",CapsuleFolder-93f63fb8-b56c-4ad1-8d3b-d651e2107423.zip
4dceea58-7d66-4576-bfc6-88c026d5b7a9,bix-52,Age-Related DNA Methylation is Equally Distributed Across Chromosomes,['Epigenomics'],https://doi.org/10.5061/dryad.wm37pvmw8,"[{""question"": ""What is the ratio of filtered (>90% or <10% methylation) age-related CpG density between chromosome W and chromosome 1 in the Zebra Finch genome?"", ""options"": [""0.5"", ""2.0"", ""1.0"", ""1.5""]}, {""question"": ""What is the genome-wide average density of age-related CpGs per base pair in the Jackdaw genome?"", ""options"": [""5.3 x 10^-7"", ""3.1 x 10^-7"", ""1.2 x 10^-6"", ""6.0 x 10^-8""]}, {""question"": ""What is the chi-square statistic for the distribution of filtered age-related CpG sites (>90% or <10% methylation) across chromosomes in the Zebra Finch genome?"", ""options"": [""156.42"", ""458.27"", ""214.93"", ""328.15""]}, {""question"": ""What is the difference in proportion of age-related CpGs found on chromosome 2 between Zebra Finch and Jackdaw?"", ""options"": [""0.08"", ""0.12"", ""0.02"", ""0.05""]}, {""question"": ""What is the density of filtered age-related CpG sites (>90% or <10% methylation) on chromosome Z in the Zebra Finch genome?"", ""options"": [""0.00000470 CpGs per base"", ""0.000000639 CpGs per base"", ""0.00000676 CpGs per base"", ""0.00000842 CpGs per base""]}, {""question"": ""Which chromosome in the Jackdaw genome shows the highest density of age-related CpG sites?"", ""options"": [""Chromosome 32"", ""Chromosome W"", ""Chromosome 1"", ""Chromosome Z""]}]",CapsuleFolder-4dceea58-7d66-4576-bfc6-88c026d5b7a9.zip
308d53bf-1513-4a09-913b-3a1112f94e7b,bix-53,UBEM2 KD in macrophages attenuates antioxidant processes in the cells,"['Differential Expression Analysis', 'RNA-seq', 'Transcriptomics']","https://zenodo.org/records/14063261, https://www.jbc.org/article/S0021-9258(24)02587-0/fulltext","[{""question"": ""What is the relative enrichment ranking of oxidative stress-related pathways compared to inflammatory response pathways in the WikiPathways analysis of UBEM2 KD effects?"", ""options"": [""Oxidative stress pathways are among the top 5 most enriched pathways"", ""Oxidative stress pathways appear only after the top 10 most enriched pathways"", ""Inflammatory response pathways and oxidative stress pathways show equal enrichment"", ""No oxidative stress pathways appear in the enrichment analysis""]}, {""question"": ""How does the removal of the third replicate from both conditions affect the number of significantly differentially expressed genes identified?"", ""options"": [""No change in the number of significant genes"", ""Decreases from 1942 to 1416 significant genes"", ""Increases from 1416 to 1942 significant genes"", ""All genes become non-significant""]}, {""question"": ""What is the number of DGEs which contribute to the glutathione metabolism pathway enrichment in the UBEM2 KD condition?"", ""options"": [""22/64 genes"", ""9/64 genes"", ""9/22 genes"", ""22/9 genes""]}, {""question"": ""What is the adjusted p-value for the enrichment of the oxidative stress pathway in the WikiPathways analysis?"", ""options"": [""1.077120e-04"", ""6.458305e-05"", ""3.011783e-06"", ""6.250315e-07""]}, {""question"": ""What is the proportion of oxidative stress-related pathways among the top 20 enriched pathways in the WikiPathways analysis?"", ""options"": [""12 out of 20 pathways"", ""8 out of 20 pathways"", ""5 out of 20 pathways"", ""2 out of 20 pathways""]}, {""question"": ""What is the most significantly enriched pathway in the KEGG analysis in the UBEM2 KD model?"", ""options"": [""TNF signaling pathway"", ""Leishmaniasis"", ""Cytokine-cytokine receptor interaction"", ""Chemokine signaling pathway""]}, {""question"": ""How does sample clustering in the PCA plot change after removing the third replicate from both conditions?"", ""options"": [""Only WT samples show remaining variation"", ""No variation remains between replicates"", ""Both conditions show equal variation"", ""Only KD samples show remaining variation""]}]",CapsuleFolder-308d53bf-1513-4a09-913b-3a1112f94e7b.zip
9e52daf6-ca58-43e8-e732-fbac3459d295,bix-54,"QS gene mutants Î”rhlI and Î”lasI demonstrate division of labor when they are co-cultured at an optimal ratio, leading to improved fitness even when compared with wildtype fitness.",['Imaging'],https://doi.org/10.17912/micropub.biology.001326,"[{""question"": ""At what frequency ratio of \u0394rhlI to total population is the maximum swarming area predicted?"", ""options"": [""0.813"", ""0.907"", ""0.500"", ""0.703""]}, {""question"": ""What is the R-squared value for the cubic model fit to the swarming area data?"", ""options"": [""0.3501"", ""0.7834"", ""0.5876"", ""0.8062""]}, {""question"": ""What is the lower bound of the 95% confidence interval for the peak swarming area according to the spline model?"", ""options"": [""159,664 mm\u00b2"", ""137,098 mm\u00b2"", ""114,531 mm\u00b2"", ""157,912 mm\u00b2""]}, {""question"": ""What is the p-value for the F-statistic in the spline model analysis of swarming area?"", ""options"": [""0.000428"", ""1.131e-11"", ""0.000287"", ""6.979e-07""]}, {""question"": ""At what frequency ratio of \u0394rhlI:\u0394lasI does the bacterial colony achieve its maximum area?"", ""options"": [""0.703"", ""0.813"", ""0.908"", ""0.500""]}, {""question"": ""What is the R-squared value for the spline model fit to the colony area data?"", ""options"": [""0.8062"", ""0.5876"", ""0.3501"", ""0.7834""]}, {""question"": ""What is the maximum colony area (in mm\u00b2) predicted across all statistical models?"", ""options"": [""184,372"", ""210,831"", ""113,394"", ""137,098""]}]",CapsuleFolder-9e52daf6-ca58-43e8-e732-fbac3459d295.zip
